The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Mar 31, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a program called the Survivorship Needs Assessment Planning (SNAP) to see how it can help both head and neck cancer survivors and their caregivers. In this study, 176 pairs of survivors and their caregivers will be divided into two groups: one will receive the SNAP program, which includes personalized support and a mobile app to help manage their care after radiation treatment, and the other group will receive usual care. The aim is to find out if SNAP can reduce the symptoms that survivors experience and lessen the stress that caregivers face. The study will also look at how SNAP affects feelings of anxiety and depression, as well as whether survivors are getting the medical care they need.

To be eligible for this trial, participants must be over 18 years old and currently undergoing radiation treatment for non-metastatic head and neck cancer. Caregivers must also be over 18 and provide support to a loved one with the same cancer. Throughout the trial, participants will complete surveys to share their experiences, and those in the SNAP group will receive additional support through a mobile app. The trial is currently recruiting participants, so if you or someone you know fits the criteria, this could be a valuable opportunity to receive extra help during the cancer journey.

Gender

ALL

Eligibility criteria

• Patient Inclusion Criteria:
• • 1. Age \>18
• • 2. Stage I-IV non-metastatic HNC (i.e., lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, larynx and cutaneous cancers)
• • 3. Currently receiving radiation treatment (with/without surgery and/or concurrent chemotherapy) with curative intent
• • 4. Able to nominate caregiver, the primary support person, also interested in participating
• Caregiver Inclusion Criteria:
• • 1. Age \>18
• • 2. Provide care for a loved one with stage I-IV HNC
• • 3. Agrees to participate after being nominated
• Patient Exclusion Criteria:
• • 1. Patients who do not read/understand English
• • 2. Patients who are cognitively impaired and cannot complete interviews as judged by the referring health care provider
• 3. Patients concurrently diagnosed with and/or receiving treatment for a second "significant" primary cancer, except the following:
• • Excised and cured non-melanoma skin cancer
• • Carcinoma in situ of breast or cervix
• • Superficial bladder cancer
• • Stage 1 differentiated thyroid cancer that is resected or observed
• • pT1a/pT1b prostate cancer comprising \<5% of resected tissue with normal prostate specific antigen (PSA) since resection
• • cT1a/cT1b prostate cancer treated with brachytherapy
• Caregiver Exclusion Criteria:
• • 1. Inability to read or understand English
• • 2. Cognitively impaired and cannot complete interviews, as judged by the referring health care provider